- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05819086
Message Testing in Aging African American Smokers (MCAAAS-2)
April 18, 2023 updated by: University of Wisconsin, Madison
Motivating Change in Aging African American Smokers - Testing Messages
The goal of this study is to examine different messages to motivate smokers who self-identify as an African American current smoker, between the ages of 50-80 years old to quit smoking.
Participants will be asked to complete a survey and look at two messages.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
844
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Wisconsin
-
Madison, Wisconsin, United States, 53705
- University of Wisconsin
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Current smoker (smoking at least some days perweek)
- Ability to read and write English
- Between the ages of 50 and 80 years old
- Self identify as African American.
Exclusion Criteria:
- History of Mild Cognitive Impairment or dementia
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: "Big tobacco" video message and flyer
Participants will view a "Big tobacco" video message and flyer.
|
Participants will view their assigned video package, and will be asked to rate their emotional response to the message
Other Names:
Participants will view their assigned video package, and will be asked to rate the impact of the presented messages on motivation to quit smoking.
Other Names:
|
|
Active Comparator: "It's never too late" video message and flyer
Participants will view a "It's never too late" video message and flyer.
|
Participants will view their assigned video package, and will be asked to rate their emotional response to the message
Other Names:
Participants will view their assigned video package, and will be asked to rate the impact of the presented messages on motivation to quit smoking.
Other Names:
|
|
Placebo Comparator: Placebo Message
Participants will view a water advertisement and flyer.
|
Participants will view their assigned video package, and will be asked to rate their emotional response to the message
Other Names:
Participants will view their assigned video package, and will be asked to rate the impact of the presented messages on motivation to quit smoking.
Other Names:
|
|
Active Comparator: Fear message video and flyer
Participants will view a fear message video and flyer.
|
Participants will view their assigned video package, and will be asked to rate their emotional response to the message
Other Names:
Participants will view their assigned video package, and will be asked to rate the impact of the presented messages on motivation to quit smoking.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Motivation to quit smoking
Time Frame: Through study completion, approximately 15 minutes
|
Measure participants' motivation to quit after viewing the flyer and video,using a 1 item scaled measurement of motivation to quit (1-7 scale, 7indicating higher motivation).
|
Through study completion, approximately 15 minutes
|
|
Emotional response
Time Frame: Through study completion, approximately 15 minutes
|
Measure participants' emotional response to the messages using a 1-9scaled measurement of 14 different emotions (9 indicating more emotionalresponse).
Emotionality will be presented together summarizing the meanpresentation of these emotions by the different groups.
|
Through study completion, approximately 15 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Adrienne Johnson, PhD, University of Wisconsin, Madison
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 13, 2023
Primary Completion (Actual)
March 28, 2023
Study Completion (Actual)
March 28, 2023
Study Registration Dates
First Submitted
April 4, 2023
First Submitted That Met QC Criteria
April 18, 2023
First Posted (Actual)
April 19, 2023
Study Record Updates
Last Update Posted (Actual)
April 19, 2023
Last Update Submitted That Met QC Criteria
April 18, 2023
Last Verified
April 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- 2023-0217
- SMPH/MEDICINE/GEN INT MD (Other Identifier: UW Madison)
- Version date 2/6/2023 (Other Identifier: UW Madison)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smoking
-
University of Southern CaliforniaAmerican Cancer Society, Inc.CompletedSmoking | Smoking Cessation | Smoking, Cigarette | Smoking Behaviors | Cessation, SmokingUnited States
-
University GhentActive, not recruitingSmoking | Smoking Tobacco | Smoking Prevention | Smoking CigaretteBelgium
-
Medical University of South CarolinaCompletedSmoking | Smoking Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
University of VirginiaRecruitingSmoking | Smoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking, Cigarette | Quitting SmokingUnited States
-
National Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Cigarette Smoking | Tobacco, SmokingUnited States
-
Maastricht University Medical CenterThe Investigative Desk; SEO Amsterdam Economics; IVO Research InstituteEnrolling by invitationSmoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking BehaviorsNetherlands
-
Jennifer Marler, MDCompletedSmoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking BehaviorsUnited States
-
Virginia Polytechnic Institute and State UniversityActive, not recruitingCigarette Smoking Behavior | Smoking Behaviors | CigaretteUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Smoking Reduction | Smoking, Tobacco | Smoking, Cigarette | Smoking Behaviors | Smoking Habit | Smoking (Tobacco) AddictionUnited States
-
Abramson Cancer Center at Penn MedicineNational Cancer Institute (NCI); New York University; Stanford UniversityCompletedSmoking | Smoking, Tobacco | Smoking, CigaretteUnited States
Clinical Trials on Rate Emotional Response
-
University of LeedsCompleted
-
Azienda Ospedaliera Cardinale G. PanicoCompletedAtrial Fibrillation | Left Ventricular DysfunctionItaly
-
University of California, Los AngelesBiotronik, Inc.TerminatedCongenital Heart Disease | Bradycardia SinusUnited States
-
Life UniversitySuspended
-
Cairo UniversityCompleted
-
Memorial Sloan Kettering Cancer CenterNovartisTerminated
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)Completed
-
Icahn School of Medicine at Mount SinaiNational Heart, Lung, and Blood Institute (NHLBI); Northwestern UniversityCompletedHypertension | Diabetes | COPDUnited States
-
Southern Methodist UniversityCompletedPhysical Activity
-
Fred Hutchinson Cancer CenterUniversity of WashingtonCompletedCancer | Hematopoietic Stem Cell TransplantationUnited States